ClinicalTrials.gg
Not yet recruitingNCT07475117HEALTH 4 MEUpdated Jul 29, 2026

Health Engagement & Access Through Learning, Training, and Health-coaching With People With Intellectual and/or Developmental Disabilities

An interventional study of Comprehensive Community Health and Regular Special Olympics programming in Intellectual Disabilities and Developmental Disability, sponsored by University of Wisconsin, Madison. Not yet recruiting at 1 site in United States. Open to participants aged 21 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-07-29.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
1,040
Allocation
Randomized
Ages
21 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to see if a combination of an educational curriculum and health coaching embedded within Special Olympics improves health outcomes and healthcare access compared to regular Special Olympics sport and health programming for adults with intellectual and/or developmental disabilities.

02

Conditions studied

  • Intellectual Disabilities
  • Developmental Disability

Keywords

  • Special Olympics
03

In context

Intellectual Disability

387 studies on the registry are indexed under Intellectual Disability; 105 are open to participants now.

This study's planned enrollment of 1,040 is above the median of 58 across 248 interventional studies indexed under Intellectual Disability.

Browse Intellectual Disability studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,188 studies on the registry; 181 are open to participants now.

Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria - Special Olympic Athletes:

  • Currently participating in Special Olympics programming at a state agency in the study
  • Has a medical or educational diagnosis of intellectual and/or developmental disabilities
  • Between the ages of 21-65
  • Has at least weekly contact with a family member or care partner who is willing and able to participate
  • Fluent in English

Inclusion Criteria - Care Partner:

  • Care partner for the participating Special Olympic Participant/Athlete
  • At least 21 years of age
  • Has at least weekly contact with Special Olympic Participant/Athlete who is willing and able to participate
  • Fluent in English

Exclusion Criteria - all:

  • Inability to complete an accessible informed assent or consent process
  • Fluctuating capacity to consent
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,040 participants (estimated)

Study arms

  • Experimental
    Comprehensive Community Health (CCH) Intervention

    Participants will receive CCH

    Behavioral: Comprehensive Community Health · Other: Regular Special Olympics programming

  • Active comparator
    Standard of Care

    Participants will receive standard ongoing Special Olympics sport and health programming

    Other: Regular Special Olympics programming

Interventions

  • BehavioralComprehensive Community Health

    Participants will receive group health coaching, psychoeducation, and group health education.

  • OtherRegular Special Olympics programming

    Standard practices for those participating in Special Olympics

06

What researchers measure

Primary outcomes

  1. Change in Goal Attainment Scaling (GAS)

    GAS is measured using three participant-identified goals, each assigned a priority weight from 1 to 3 (3=most important goal to participant). At each assessment, each goal is assigned a score from -2 to +2, with 0 representing expected level of attainment and 2 indicating much more than expected level of attainment; goals are assigned a score of -2 at baseline. GAS score levels across all three participant goals are converted into a standardized single GAS T-score for each participant. The range of possible T-scores is 23.56 (all three goals with GAS score of -2) to 76.44 (all three goals with GAS score of +2).

    Time frame: Baseline to 1, 3, 6, 12, and 18 months

Secondary outcomes

  1. Change in number of doctor visits

    Participants will self-report how many times they visited their adult or family-care practitioner over the course of the study

    Time frame: Baseline, 1, 3, 6, 12, and 18 months

  2. Change in number of routine health check-ups

    Participants will self-report whether they received routine care throughout the study

    Time frame: Baseline, 1, 3, 6, 12, and 18 months

  3. Change in number of participants with intellectual and/or developmental disabilities that follow-up with their primary physician

    Participants will self-report whether they followed-up with their primary physician using HEALTH 4 ME tools to inform them of risk or concern about their health.

    Time frame: Baseline, 1, 3, 6, 12, and 18 months

  4. Change in quality of life - "Healthy Days Measure"

    The CDC HRQOL-14 (Healthy Days Measures) scoring involves creating an Unhealthy Days Score by summing days with poor physical and mental health (max 30), and a Healthy Days Score (30 minus unhealthy days); individual items (general health, symptoms like pain, depression, energy) are often scored separately (0-30 for days, 1-5 for general health), with higher scores generally indicating worse health, except for energy/lack of fatigue, where higher is better. There isn't a single, complex summary score, but rather metrics for different aspects of quality of life, reported as means or percentages.

    Time frame: Baseline, 1, 3, 6, 12, and 18 months

  5. Change in healthcare access satisfaction

    Participants will self-report their satisfaction with healthcare access via responses to 3 survey items, scored on a 3-point Likert scale where 1 = easy and 3 = hard. Scores range from 3-9 with lower scores indicating greater satisfaction.

    Time frame: Baseline, 3, 12, and 18 months post-intervention

  6. Change in healthcare use satisfaction

    Participants will self-report their satisfaction with healthcare use via responses to 3 survey items. Items are scored on a 3-point Likert scale, where 1 = very satisfied and 3 = not satisfied. Scores range from 3-9 with higher scores indicating lower level of satisfaction.

    Time frame: Baseline, 3, 12, and 18 months post-intervention

  7. Change in self-advocacy

    Participants will be interviewed regarding their perceptions and understanding of health self-advocacy.

    Time frame: Baseline, 3, 12, and 18 months post-intervention

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Coded data will be submitted to the Patient-Centered Outcomes Data Repository (PCODR) at the Inter-university Consortium for Political and Social Research (CPSR) at the University of Michigan, as required by PCORI. The shared dataset will include participant-level quantitative data, relevant study documentation, and supporting materials necessary to enable secondary analyses. Prior to submission to PCODR, all data will be de-identified but will have study ID codes. Direct identifiers will be removed, and dates will be generalized or shifted as appropriate to minimize re-identification risk.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Mar 2031, 54 months later.

Of 155 non-industry interventional studies with no phase under Intellectual Disability, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 54 months is above that.

Counting every sponsor, half of 158 studies reached it within 19 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 11, 2026
First posted
Mar 16, 2026
StartEst.
Sep 2026
Primary completionEst.
Mar 2031
CompletionEst.
Mar 2031
Last update
Jul 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07475117
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Sponsor
First posted
Mar 16, 2026
Start date
Sep 2026 (estimated)
Primary completion
Mar 2031 (estimated)
Completion
Mar 2031 (estimated)
Last update
Jul 29, 2026

Study contacts

Karla Ausderau, PhD
Contact
kausderau@wisc.edu
608-262-0653
Karla Ausderau, PhD
principal investigator · University of Wisconsin, Madison

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion